Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1982-03-05
1983-11-22
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
A61K 3702
Patent
active
044168748
ABSTRACT:
BBM-928A solutions suitable for parenteral use in animal experiments and having concentrations in the range of 1 mg/ml to 5 mg/ml are described.
REFERENCES:
patent: 4360458 (1982-11-01), Koshiyama et al.
Del et al., J.A.C.S., 97, 2497-2502 (1975).
Osol, Remington's Pharmaceutical Sciences, 16th Ed., p. 1265, Mack Publishing Co., Easton, Pennsylvania (1980).
Windhalz, The Merck Index, 9th Ed. Merck and Co. Inc., p. 1115 (1976).
Physicians Desk Reference, 37th Edition, 1983, Parenteral Dilantin.
Kaplan Murray A.
Shinal Edward C.
Bristol-Myers Company
Carnahan Robert E.
Moezie F. T.
Phillips Delbert R.
LandOfFree
Injectable compositions of BBM-928A does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injectable compositions of BBM-928A, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable compositions of BBM-928A will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1814698